skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:054392/0656   Pages: 4
Recorded: 11/12/2020
Attorney Dkt #:VARIOUS
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 28
1
Patent #:
6946129
Issue Dt:
09/20/2005
Application #:
09328296
Filing Dt:
06/08/1999
Title:
RECOMBINANT ANTI-CD40 ANTIBODY AND USES THEREOF
2
Patent #:
7090843
Issue Dt:
08/15/2006
Application #:
09724406
Filing Dt:
11/28/2000
Title:
RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF
3
Patent #:
6838261
Issue Dt:
01/04/2005
Application #:
09724409
Filing Dt:
11/28/2000
Title:
NUCLEIC ACIDS ENCODING ANTI-CD40 PROTEINS AND METHODS OF PRODUCING RECOMBINANT ANTI-CD40 PROTEINS
4
Patent #:
6843989
Issue Dt:
01/18/2005
Application #:
09724530
Filing Dt:
11/28/2000
Title:
METHODS FOR THE TREATMENT AND PREVENTION OF CANCER USING ANTI-CD40 ANTIBODIES
5
Patent #:
7659241
Issue Dt:
02/09/2010
Application #:
10522911
Filing Dt:
07/07/2005
Publication #:
US20060074008
Pub Dt:
04/06/2006
Title:
DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE
6
Patent #:
7510711
Issue Dt:
03/31/2009
Application #:
11102743
Filing Dt:
04/08/2005
Publication #:
US20050266002
Pub Dt:
12/01/2005
Title:
METHODS FOR THE TREATMENT OF CANCER USING ANTI-CD40 ANTIBODIES
7
Patent #:
7695716
Issue Dt:
04/13/2010
Application #:
12101785
Filing Dt:
04/11/2008
Publication #:
US20080267960
Pub Dt:
10/30/2008
Title:
METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES
8
Patent #:
7968687
Issue Dt:
06/28/2011
Application #:
12253895
Filing Dt:
10/17/2008
Publication #:
US20090136526
Pub Dt:
05/28/2009
Title:
CD19 BINDING AGENTS AND USES THEREOF
9
Patent #:
7666422
Issue Dt:
02/23/2010
Application #:
12356511
Filing Dt:
01/20/2009
Publication #:
US20090280117
Pub Dt:
11/12/2009
Title:
METHODS FOR THE TREATMENT OF CANCER USING ANTI-CD40 ANTIBODIES
10
Patent #:
7829531
Issue Dt:
11/09/2010
Application #:
12408646
Filing Dt:
03/20/2009
Publication #:
US20090324621
Pub Dt:
12/31/2009
Title:
DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE
11
Patent #:
8257706
Issue Dt:
09/04/2012
Application #:
12438604
Filing Dt:
05/20/2009
Publication #:
US20100239571
Pub Dt:
09/23/2010
Title:
CD30 BINDING AGENTS AND USES THEREOF
12
Patent #:
7851437
Issue Dt:
12/14/2010
Application #:
12621406
Filing Dt:
11/18/2009
Publication #:
US20100062008
Pub Dt:
03/11/2010
Title:
DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE
13
Patent #:
7824683
Issue Dt:
11/02/2010
Application #:
12648108
Filing Dt:
12/28/2009
Publication #:
US20100158906
Pub Dt:
06/24/2010
Title:
METHODS FOR AUGMENTING AN IMMUNE RESPONSE USING ANTI-CD40 ANTIBODIES
14
Patent #:
8263083
Issue Dt:
09/11/2012
Application #:
12681599
Filing Dt:
04/02/2010
Publication #:
US20100215671
Pub Dt:
08/26/2010
Title:
COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES
15
Patent #:
8906376
Issue Dt:
12/09/2014
Application #:
12880028
Filing Dt:
09/10/2010
Publication #:
US20110064753
Pub Dt:
03/17/2011
Title:
DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE
16
Patent #:
8758758
Issue Dt:
06/24/2014
Application #:
12985687
Filing Dt:
01/06/2011
Title:
POST-RELAPSE TREATMENT OF CD30 EXPRESSING LYMPHOMAS
17
Patent #:
8242252
Issue Dt:
08/14/2012
Application #:
13109957
Filing Dt:
05/17/2011
Publication #:
US20110312088
Pub Dt:
12/22/2011
Title:
CD19 BINDING AGENTS AND USES THEREOF
18
Patent #:
9211319
Issue Dt:
12/15/2015
Application #:
13143338
Filing Dt:
07/05/2011
Publication #:
US20110268751
Pub Dt:
11/03/2011
Title:
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
19
Patent #:
9073993
Issue Dt:
07/07/2015
Application #:
13530074
Filing Dt:
06/21/2012
Publication #:
US20120294853
Pub Dt:
11/22/2012
Title:
CD19 Binding Agents and Uses Thereof
20
Patent #:
8470329
Issue Dt:
06/25/2013
Application #:
13571313
Filing Dt:
08/13/2012
Publication #:
US20130022627
Pub Dt:
01/24/2013
Title:
COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES
21
Patent #:
10444241
Issue Dt:
10/15/2019
Application #:
14376957
Filing Dt:
08/06/2014
Publication #:
US20140377286
Pub Dt:
12/25/2014
Title:
DETECTION AND TREATMENT OF CD30+ CANCERS
22
Patent #:
9587019
Issue Dt:
03/07/2017
Application #:
14401837
Filing Dt:
11/17/2014
Publication #:
US20150147316
Pub Dt:
05/28/2015
Title:
CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
23
Patent #:
9919061
Issue Dt:
03/20/2018
Application #:
14743318
Filing Dt:
06/18/2015
Publication #:
US20180000961
Pub Dt:
01/04/2018
Title:
CD19 BINDING AGENTS AND USES THEREOF
24
Patent #:
9713648
Issue Dt:
07/25/2017
Application #:
14938658
Filing Dt:
11/11/2015
Publication #:
US20160129130
Pub Dt:
05/12/2016
Title:
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
25
Patent #:
10787514
Issue Dt:
09/29/2020
Application #:
15411947
Filing Dt:
01/20/2017
Publication #:
US20170204180
Pub Dt:
07/20/2017
Title:
CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
26
Patent #:
10098963
Issue Dt:
10/16/2018
Application #:
15622496
Filing Dt:
06/14/2017
Publication #:
US20170281794
Pub Dt:
10/05/2017
Title:
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
27
Patent #:
10478469
Issue Dt:
11/19/2019
Application #:
16375745
Filing Dt:
04/04/2019
Publication #:
US20190224268
Pub Dt:
07/25/2019
Title:
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
28
Patent #:
10722549
Issue Dt:
07/28/2020
Application #:
16595430
Filing Dt:
10/07/2019
Publication #:
US20200030405
Pub Dt:
01/30/2020
Title:
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
Assignor
1
SEATTLE GENETICS, INC.
Exec Dt:
10/06/2020
Assignee
1
SEAGEN INC.
21823 30TH DRIVE SE
BOTHELL, WASHINGTON 98021
Correspondence name and address
SEAGEN INC.
21823 30TH DRIVE SE
BOTHELL, WA 98021

Search Results as of: 05/10/2024 08:01 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT